Physician profile
Evan Saenger
NPI 1306342803
$14,630.31
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.31 · 2023: $253 · 2024: $808 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,091 · Food and Beverage: $2,695 · Travel and Lodging: $1,818 · Education: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,090.90 |
| Food and Beverage | $2,695.30 |
| Travel and Lodging | $1,817.64 |
| Education | $934.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,404.06 | 2023-2025 | Watchman, General - Therapies, General - Ep |
| Abbott Laboratories | $3,484.57 | 2024-2025 | Assurity, Tacticath, Ensite |
| Medtronic, INC. | $191.46 | 2025 | Azure Xt Dr Mri Surescan |
| Abiomed | $134.39 | 2022-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.22 | 2022-2025 | Lifevest |
| Janssen Scientific Affairs, LLC | $80.15 | 2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $64.50 | 2023 | Definity |
| Biosense Webster, INC. | $58.45 | 2025 | Carto 3 |
| Cardiva Medical, INC. | $31.69 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $27.07 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Saenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.